OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 60 filers reported holding OYSTER PT PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,304 | -99.6% | 206,254 | +93.6% | 0.00% | – |
| Q3 2022 | $599,000 | +2.7% | 106,551 | -20.9% | 0.00% | – |
| Q2 2022 | $583,000 | -73.3% | 134,638 | +12.4% | 0.00% | -100.0% |
| Q4 2021 | $2,187,000 | +383.8% | 119,783 | +213.8% | 0.00% | – |
| Q3 2021 | $452,000 | -26.0% | 38,172 | +7.3% | 0.00% | – |
| Q2 2021 | $611,000 | -43.1% | 35,559 | -39.4% | 0.00% | -100.0% |
| Q1 2021 | $1,073,000 | -46.4% | 58,688 | -44.8% | 0.00% | 0.0% |
| Q4 2020 | $2,000,000 | -41.8% | 106,268 | -34.7% | 0.00% | -75.0% |
| Q3 2020 | $3,437,000 | -6.5% | 162,815 | +27.9% | 0.00% | -20.0% |
| Q2 2020 | $3,677,000 | +1541.5% | 127,310 | +1885.5% | 0.01% | +400.0% |
| Q1 2020 | $224,000 | -9.3% | 6,412 | -36.6% | 0.00% | – |
| Q4 2019 | $247,000 | – | 10,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $15,559,000 | 8.54% |
| NEA Management Company, LLC | 5,925,287 | $33,300,000 | 1.66% |
| KPCB XIV Associates, LLC | 367,987 | $2,068,000 | 1.61% |
| Paradigm Biocapital Advisors LP | 1,648,316 | $9,264,000 | 1.24% |
| Telemark Asset Management, LLC | 777,026 | $4,367,000 | 0.69% |
| COWEN AND COMPANY, LLC | 509,794 | $2,865,000 | 0.27% |
| RTW INVESTMENTS, LP | 2,044,312 | $11,489,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $5,843,000 | 0.12% |
| Wildcat Capital Management, LLC | 36,847 | $207,000 | 0.08% |
| ACT CAPITAL MANAGEMENT, LLC | 8,500 | $48,000 | 0.07% |